Brian Kevin Kaspar

2004 University of California, San Diego, La Jolla, CA 
"Brian Kaspar"
Mean distance: 14.05 (cluster 6)


Sign in to add mentor
Fred H. (Rusty) Gage grad student 2004 UCSD
 (Retrograde viral delivery of IGF-1 prolongs survival in a mouse model of ALS.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Iwayama H, Liao XH, Braun L, et al. (2016) Adeno associated virus 9-based gene therapy delivers a functional monocarboxylate transporter 8 (MCT8) which improves thyroid hormone availability to brain of Mct8 deficient mice. Thyroid : Official Journal of the American Thyroid Association
Ahmed SS, Schattgen SA, Frakes AE, et al. (2016) rAAV gene therapy in a Canavan's disease mouse model reveals immune impairments and an extended pathology beyond the central nervous system. Molecular Therapy : the Journal of the American Society of Gene Therapy
Bockstael O, Foust KD, Kaspar B, et al. (2011) Recombinant AAV delivery to the central nervous system. Methods in Molecular Biology (Clifton, N.J.). 807: 159-77
Peterson JM, Kline W, Canan BD, et al. (2011) Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Molecular Medicine (Cambridge, Mass.). 17: 508-15
Foust KD, Kaspar BK. (2011) Delivery strategies for RNAi to the nervous system Neuromethods. 58: 59-76
Kaspar BK. (2010) Gene therapy: Direct viral delivery Encyclopedia of Neuroscience. 633-639
Kim ML, Chandrasekharan K, Glass M, et al. (2008) O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptors. Molecular and Cellular Neurosciences. 39: 452-64
Koerber JT, Excoffon K, Kaspar B, et al. (2008) Engineering of a novel AAV vector in a human airway model system for cystic fibrosis gene therapy Aiche Annual Meeting, Conference Proceedings
Suhonen J, Ray J, Blömer U, et al. (2006) Ex vivo and in vivo gene delivery to the brain. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 13.3
Lee GK, Maheshri N, Kaspar B, et al. (2005) PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnology and Bioengineering. 92: 24-34
See more...